Synthesis and N-Methyl-D-aspartate (NMDA) Receptor Activity of Ketamine Metabolites

被引：65

作者：

Morris, Patrick J. ^{[1
]}

Moaddel, Ruin ^{[2
]}

Zanos, Panos ^{[3
]}

Moore, Curtis E. ^{[4
]}

Gould, Todd ^{[3
,5
,6
]}

Zarate, Carlos A., Jr. ^{[7
]}

Thomas, Craig J. ^{[1
]}

机构：

[1] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA

[2] NIA, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA

[3] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA

[4] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA

[5] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA

[6] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA

[7] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, Bethesda, MD 20892 USA

来源：

ORGANIC LETTERS | 2017年 / 19卷 / 17期

关键词：

ANTIDEPRESSANT; MECHANISMS; DEPRESSION; AMINATION; CURRENTS; PLASMA;

D O I：

10.1021/acs.orglett.7b02177

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Ketamine is rapidly metabolized in the human body to a variety of metabolites, including the hydroxynorketamines. At least two hydroxynorketamines have significant antidepressant action in rodent models, with limited action against the N-methyl-D-aspartate (NMDA) receptor. The synthesis of 12 hydroxynorketamines and their binding affinity to the NMDA receptor is presented here.

引用

页码：4572 / 4575

页数：4

共 50 条

[21] INFLUENCING CHONDROGENESIS VIA THE N-METHYL-D-ASPARTATE (NMDA) RECEPTOR PATHWAY
Zakany, R.
Juhasz, T.
Fodor, J.
Takacs, R.
Vago, J.
Csernoch, L.
Matta, C.
OSTEOARTHRITIS AND CARTILAGE, 2020, 28 : S104 - S105
[22] N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTAGONIST AND ASD: A SYSTEMATIC REVIEW
Gupta, Nihit
Gupta, Mayank
Emereonye, Kelechi N.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S296 - S296
[23] Implication of Genes for the N-Methyl-d-Aspartate (NMDA) Receptor in Substance Addictions
Chen, Jiali
Ma, Yunlong
Fan, Rongli
Yang, Zhongli
Li, Ming D.
MOLECULAR NEUROBIOLOGY, 2018, 55 (09) : 7567 - 7578
[24] Implication of Genes for the N-Methyl-d-Aspartate (NMDA) Receptor in Substance Addictions
Jiali Chen
Yunlong Ma
Rongli Fan
Zhongli Yang
Ming D. Li
Molecular Neurobiology, 2018, 55 : 7567 - 7578
[25] PNEUMOTAXIC MECHANISMS IN THE NONHUMAN PRIMATE - EFFECT OF THE N-METHYL-D-ASPARTATE (NMDA) ANTAGONIST KETAMINE
PIERREFICHE, O
FOUTZ, AS
DENAVITSAUBIE, M
NEUROSCIENCE LETTERS, 1990, 119 (01) : 90 - 93
[26] Protein kinase C potentiation of N-methyl-D-aspartate receptor activity is not mediated by phosphorylation of N-methyl-D-aspartate receptor subunits
Zheng, X
Zhang, L
Wang, AP
Bennett, MVL
Zukin, RS
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 15262 - 15267
[27] Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity
Stahl, Stephen M.
CNS SPECTRUMS, 2019, 24 (05) : 461 - 466
[28] THE N-METHYL-D-ASPARTATE RECEPTOR COMPLEX
WILLIAMS, M
LOO, PA
MURPHY, DE
BRAUNWALDER, AF
JARVIS, MF
SILLS, MA
JOURNAL OF RECEPTOR RESEARCH, 1988, 8 (1-4): : 195 - 203
[29] The effect of ketamine on N-methyl-D-aspartate receptor subunit expression in neonatal rats
Han, Li-Chun
Yao, Li-nong
Wu, Sheng-xi
Yang, Yong-hui
Xu, Li-Xian
Chai, Wei
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2010, 27 (02) : 181 - 186
[30] The stereoselective effects of ketamine isomers on heteromeric N-methyl-D-aspartate receptor channels
Yamakura, T
Sakimura, K
Shimoji, K
ANESTHESIA AND ANALGESIA, 2000, 91 (01): : 225 - 229

← 1 2 3 4 5 →